Sanofi to build vaccine plant in China

Vaccines made in China--for China. Sanofi Pasteur says it's spending about $104 million on a Chinese manufacturing plant in hopes of launching flu shots locally by 2012. The plant will be in Shenzhen, South China, where the company already operates a filling and packing facility. Construction on the plant will start next year. When it's up and running, it will have 100 employees and a capacity of 25 million doses, but Sanofi hopes to double that within 10 to 15 years.

- read the report from Dow Jones

Related Articles:
Sanofi signs stem cell pact in China. Report
Sanofi vaccine effective against new bird flu strains. Report
China pushes drug development as R&D soars. Report

Suggested Articles

Hengrui's Sun Piaoyang is stepping down as chairman, but he'll retain control of the pharma major he's headed for 30 years—and made a fortune…

Astellas tapped Adaptimmune to develop T-cell therapies. Ireland hit Takeda with an unexpected Shire tax bill. PD-1 med Tyvyt hit its goal in NSCLC.

AbbVie and Allergan's merger may create the fourth-largest drugmaker in the world, but it could also create opportunities for other drugmakers.